Cilostazol Augmentation Study in Dementia

clinical trial

Details

Instance of: clinical trial
Start time: May 2010
End time: June 2012
Main subject: cilostazol, dementia
clinical trial phase: phase IV clinical trial
minimum age: 60
number of participants: 46
research intervention: donepezil, cilostazol
study type: interventional study
title: Cilostazol Augmentation Study In Dementia (CASID): A Randomized, Placebo-controlled Pilot Study to Compare the Efficacy Between Donepezil Monotherapy and Cilostazol Augmentation Therapy in Alzheimer's Disease Patients With Subcortical White Matter Hyperintensities

Nothing in the MetaHistoryBook collection references this item yet.